Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
AIkido Pharma Inc. Market Cap
Based on ratings from 0 stock analysts, the AIkido Pharma Inc. stock price is expected to decrease by 100% in 12 months. This is calculated by using the average 12-month stock price forecast for AIkido Pharma Inc.. The lowest target is $ and the highest is $. Please note analyst price targets are not guaranteed and could be missed completely.
About 0 Wall Street analysts have assignedDOMH 0 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect AIkido Pharma Inc. to sell. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on DOMH. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of DOMH.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
HC Wainwright & Co. | Buy | Maintains | Nov 11, 2022 |
When did it IPO
1980
Staff Count
26
Country
United States
Sector/Industry
Healthcare/Biotechnology
CEO
Mr. Anthony C. Hayes Esq.
Market Cap
$10.1M
In 2023, DOMH generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that DOMH's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Mon, 11 Nov 2024
Sentiment - NEUTRAL
Source - Accesswire
Summary - Dominari Holdings Inc. has appointed Edward Deignan as VP of Finance and Accounting and Kyle Degruttola as Controller, enhancing its financial leadership team.
Why It Matters - Leadership changes in finance roles can signal a shift in strategy or company direction, impacting operational efficiency and financial performance, which are crucial for investor confidence and stock valuation.
Mon, 07 Oct 2024
Sentiment - NEUTRAL
Source - Accesswire
Summary - Dominari Holdings Inc. announced the appointment of James Hopkins as Managing Director Head of Capital Markets for its subsidiary, Dominari Securities LLC, to enhance its financial services offerings.
Why It Matters - The appointment of James Hopkins strengthens Dominari's capital markets expertise, enhancing its growth potential and signaling a commitment to expanding its financial services, which could boost investor confidence.
Tue, 13 Aug 2024
Sentiment - NEUTRAL
Source - Accesswire
Summary - Dominari Holdings Inc. (Nasdaq: DOMH) announced that its subsidiary, Dominari Securities LLC, has been approved as a Limited Underwriting Member of Nasdaq, allowing it to act as a principal underwriter.
Why It Matters - Dominari Holdings' approval as a Limited Underwriting Member enhances its market position, potentially increasing revenue streams and investor confidence in the company's growth trajectory.
Wed, 17 Apr 2024
Sentiment - NEUTRAL
Source - Accesswire
Summary - Dominari Holdings Inc. (Nasdaq: DOMH) has appointed Steve Kann and Andre Peschong as Managing Directors at its subsidiary, Dominari Securities LLC, to enhance its financial services capabilities.
Why It Matters - The addition of seasoned professionals enhances Dominari's leadership, potentially leading to improved strategic execution and growth, which can positively impact stock performance and investor confidence.
Fri, 15 Mar 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Dominari Holdings Inc. appointed Eric Newman as Executive Vice President of its subsidiary, Dominari Securities LLC, to enhance investment banking and brokerage operations.
Why It Matters - Eric Newman's appointment enhances Dominari Securities' investment banking and brokerage capabilities, potentially improving performance and shareholder value, which could positively impact stock prices.
Tue, 12 Mar 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Dominari Holdings Inc. has appointed Dr. Cosme Ordoñez as Head of Investment Banking for its subsidiary, Dominari Securities LLC, enhancing its healthcare sector coverage.
Why It Matters - The appointment of Dr. Cosme Ordoñez enhances Dominari Securities' expertise in healthcare investment banking, potentially improving deal flow and profitability, which can positively impact stock performance.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
